{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06388187",
            "orgStudyIdInfo": {
                "id": "NN9838-7749"
            },
            "secondaryIdInfos": [
                {
                    "id": "U1111-1298-3451",
                    "type": "OTHER",
                    "domain": "World Health Organization (WHO)"
                },
                {
                    "id": "2023-509273-24",
                    "type": "OTHER",
                    "domain": "European Medical Agency (EMA)"
                }
            ],
            "organization": {
                "fullName": "Novo Nordisk A/S",
                "class": "INDUSTRY"
            },
            "briefTitle": "A Research Study to See How Well Different Doses of CagriSema Help People With Excess Body Weight Lose Weight",
            "officialTitle": "Efficacy and Safety of Cagrilintide s.c. in Combination With Semaglutide s.c.(CagriSema s.c. 1.0 mg/1.0 mg and 1.7 mg/1.7 mg) Once-weekly in Participants With Overweight or Obesity",
            "therapeuticArea": [
                "Endocrinology"
            ],
            "study": "a-research-study-to-see-how-well-different-doses-of-cagrisema-help-people-with-excess-body-weight-lose-weight"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-06-24",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2026-02-27",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-04-10",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2024-04-24",
            "studyFirstSubmitQcDate": "2024-04-24",
            "studyFirstPostDateStruct": {
                "date": "2024-04-29",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-16",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-18",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Novo Nordisk A/S",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This study will look at how well CagriSema helps people with excess body weight lose weight. CagriSema is a new medicine developed by Novo Nordisk that combines cagrilintide and semaglutide. CagriSema cannot yet be prescribed by doctors. In the study, participant will either get CagriSema or dummy medicine and which treatment participant get is decided by chance. The study will last for about 1\u00bd years for each participant."
        },
        "conditionsModule": {
            "conditions": [
                "Obesity"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE3"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "QUADRUPLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "CARE_PROVIDER",
                        "INVESTIGATOR",
                        "OUTCOMES_ASSESSOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 300,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "CagriSema Dose 1",
                    "type": "EXPERIMENTAL",
                    "description": "Participants will receive once-weekly subcutaneous (s.c) injections of CagriSema (cagrilintide and semaglutide) at escalating doses every week in 8-week dose escalation period until target dose (dose 1) of CagriSema (cagrilintide and semaglutide) is achieved and maintained up to 60 weeks.",
                    "interventionNames": [
                        "Drug: Cagrilintide",
                        "Drug: Semaglutide"
                    ]
                },
                {
                    "label": "Placebo Dose 1",
                    "type": "PLACEBO_COMPARATOR",
                    "description": "Participants will receive once-weekly s.c injection of placebo matched to cagrisema dose 1 (cagrilintide and semaglutide) for 68 weeks.",
                    "interventionNames": [
                        "Drug: Placebo"
                    ]
                },
                {
                    "label": "CagriSema Dose 2",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "Participants will receive once-weekly s.c injections of CagriSema (cagrilintide and semaglutide) at escalating doses every week in 12-week dose escalation period until target dose (dose 2) of CagriSema(cagrilintide and semaglutide) is achieved and maintained up to 56 weeks.",
                    "interventionNames": [
                        "Drug: Cagrilintide",
                        "Drug: Semaglutide"
                    ]
                },
                {
                    "label": "Placebo Dose 2",
                    "type": "PLACEBO_COMPARATOR",
                    "description": "Participants will receive once-weekly s.c injection of placebo matched to cagrisema dose 2 (cagrilintide and semaglutide) for 68 weeks.",
                    "interventionNames": [
                        "Drug: Placebo"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Cagrilintide",
                    "description": "Participants will receive once-weekly cagrilintide subcutaneously.",
                    "armGroupLabels": [
                        "CagriSema Dose 1",
                        "CagriSema Dose 2"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Semaglutide",
                    "description": "Participants will receive once-weekly semaglutide subcutaneously.",
                    "armGroupLabels": [
                        "CagriSema Dose 1",
                        "CagriSema Dose 2"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Placebo",
                    "description": "Participants will receive once-weekly placebo matched to cagrilintide and semaglutide subcutaneously.",
                    "armGroupLabels": [
                        "Placebo Dose 1",
                        "Placebo Dose 2"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Relative change in body weight",
                    "description": "Measured in percentage (%).",
                    "timeFrame": "From baseline (week 0) to end of treatment (week 68)"
                },
                {
                    "measure": "Achievement of \u22655% weight reduction",
                    "description": "Measured as count of participant.",
                    "timeFrame": "From baseline (week 0) to end of treatment (week 68)"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Achievement of \u226510% weight reduction",
                    "description": "Measured as count of participant.",
                    "timeFrame": "From baseline (week 0) to end of treatment (week 68)"
                },
                {
                    "measure": "Achievement of \u226515% weight reduction",
                    "description": "Measured as count of participant.",
                    "timeFrame": "From baseline (week 0) to end of treatment (week 68)"
                },
                {
                    "measure": "Achievement of \u226520% weight reduction",
                    "description": "Measured as count of participant.",
                    "timeFrame": "From baseline (week 0) to end of treatment (week 68)"
                },
                {
                    "measure": "Change in waist circumference",
                    "description": "Measured in centimeter (cm).",
                    "timeFrame": "From baseline (week 0) to end of treatment (week 68)"
                },
                {
                    "measure": "Change in systolic blood pressure",
                    "description": "Measured in millimeters of mercury.",
                    "timeFrame": "From baseline (week 0) to end of treatment (week 68)"
                },
                {
                    "measure": "Ratio to baseline in lipids: Total cholesterol",
                    "description": "Measured in ratio.",
                    "timeFrame": "From baseline (week 0) to end of treatment (week 68)"
                },
                {
                    "measure": "Ratio to baseline in lipids: High-density lipoprotein (HDL) cholesterol",
                    "description": "Measured in ratio.",
                    "timeFrame": "From baseline (week 0) to end of treatment (week 68)"
                },
                {
                    "measure": "Ratio to baseline in lipids: Low-density lipoprotein (LDL) cholesterol",
                    "description": "Measured in ratio.",
                    "timeFrame": "From baseline (week 0) to end of treatment (week 68)"
                },
                {
                    "measure": "Ratio to baseline in lipids: Very low-density lipoprotein (VLDL) cholesterol",
                    "description": "Measured in ratio.",
                    "timeFrame": "From baseline (week 0) to end of treatment (week 68)"
                },
                {
                    "measure": "Ratio to baseline in lipids: Triglycerides",
                    "description": "Measured in ratio.",
                    "timeFrame": "From baseline (week 0) to end of treatment (week 68)"
                },
                {
                    "measure": "Ratio to baseline in lipids: Free fatty acids",
                    "description": "Measured in ratio.",
                    "timeFrame": "From baseline (week 0) to end of treatment (week 68)"
                },
                {
                    "measure": "Number of treatment emergent adverse events (TEAEs)",
                    "description": "Measured as count of events.",
                    "timeFrame": "From baseline (week 0) to end of study (week 74)"
                },
                {
                    "measure": "Number of treatment emergent serious adverse events (TESAEs)",
                    "description": "Measured as count of events.",
                    "timeFrame": "From baseline (week 0) to end of study (week 74)"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Male or female\n* Age above or equal to 18 years at the time of signing informed consent\n\n  1. Body Mass index (BMI) greater than or equal to (\u2265) 30.0 kilogram per meter square (kg/m\\^2) or\n  2. BMI \u226527.0 kg/m2 with the presence of at least one obesity related complication including, but not limited to hypertension, dyslipidaemia, obstructive sleep apnoea or cardiovascular disease\n\nExclusion Criteria:\n\n* Glycated haemoglobin (HbA1c) \u22656.5% (48 millimoles per mole \\[mmol/mol\\]) as measured by the central laboratory at screening\n* History of type 1 or type 2 diabetes",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Novo Nordisk",
                    "role": "CONTACT",
                    "phone": "(+1) 866-867-7178",
                    "email": "clinicaltrials@novonordisk.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Clinical Transparency (dept. 2834)",
                    "affiliation": "Novo Nordisk A/S",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "Aurora FDRC Inc.",
                    "status": "RECRUITING",
                    "city": "Costa Mesa",
                    "state": "California",
                    "zip": "92627",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 33.64113,
                        "lon": -117.91867
                    }
                },
                {
                    "facility": "Clinical Trial Res Assoc,Inc",
                    "status": "RECRUITING",
                    "city": "Plantation",
                    "state": "Florida",
                    "zip": "33324",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 26.13421,
                        "lon": -80.23184
                    }
                },
                {
                    "facility": "Midwest Inst For Clin Res",
                    "status": "RECRUITING",
                    "city": "Indianapolis",
                    "state": "Indiana",
                    "zip": "46260",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 39.76838,
                        "lon": -86.15804
                    }
                },
                {
                    "facility": "Accellacare",
                    "status": "RECRUITING",
                    "city": "Wilmington",
                    "state": "North Carolina",
                    "zip": "28401",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 34.22573,
                        "lon": -77.94471
                    }
                },
                {
                    "facility": "Velocity Clinical Res-Dallas",
                    "status": "RECRUITING",
                    "city": "Dallas",
                    "state": "Texas",
                    "zip": "75230",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 32.78306,
                        "lon": -96.80667
                    }
                },
                {
                    "facility": "Washington Cntr Weight Mgmt",
                    "status": "RECRUITING",
                    "city": "Arlington",
                    "state": "Virginia",
                    "zip": "22206",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 38.88101,
                        "lon": -77.10428
                    }
                },
                {
                    "facility": "Capital Clin Res Ctr,LLC",
                    "status": "RECRUITING",
                    "city": "Olympia",
                    "state": "Washington",
                    "zip": "98502",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 47.03787,
                        "lon": -122.9007
                    }
                },
                {
                    "facility": "Ocean West Research Clinic",
                    "status": "RECRUITING",
                    "city": "Surrey",
                    "state": "British Columbia",
                    "zip": "V3Z 2N6",
                    "country": "Canada",
                    "geoPoint": {
                        "lat": 49.10635,
                        "lon": -122.82509
                    }
                },
                {
                    "facility": "Nova Scotia Health Authority",
                    "status": "RECRUITING",
                    "city": "Halifax",
                    "state": "Nova Scotia",
                    "zip": "B3H 1V7",
                    "country": "Canada",
                    "geoPoint": {
                        "lat": 44.64533,
                        "lon": -63.57239
                    }
                },
                {
                    "facility": "Wharton Med Clin Trials",
                    "status": "RECRUITING",
                    "city": "Hamilton",
                    "state": "Ontario",
                    "zip": "L8L 5G8",
                    "country": "Canada",
                    "geoPoint": {
                        "lat": 43.25011,
                        "lon": -79.84963
                    }
                },
                {
                    "facility": "Hospices Civils de Lyon-Hopital Lyon Sud-1",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Pierre-Benite",
                    "zip": "69310",
                    "country": "France",
                    "geoPoint": {
                        "lat": 45.7009,
                        "lon": 4.82511
                    }
                },
                {
                    "facility": "Centre Hospitalier Universitaire de Nantes-Hopital Nord Laennec-1",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Saint Herblain",
                    "zip": "44800",
                    "country": "France",
                    "geoPoint": {
                        "lat": 47.21765,
                        "lon": -1.64841
                    }
                },
                {
                    "facility": "Centre Hospitalier Universitaire de Toulouse-Hopital Rangueil-1",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Toulouse Cedex 9",
                    "zip": "31059",
                    "country": "France",
                    "geoPoint": {
                        "lat": 43.60426,
                        "lon": 1.44367
                    }
                },
                {
                    "facility": "InnoDiab Forschung GmbH",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Essen",
                    "zip": "45136",
                    "country": "Germany",
                    "geoPoint": {
                        "lat": 51.45657,
                        "lon": 7.01228
                    }
                },
                {
                    "facility": "Wendisch/Dahl Hamburg",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Hamburg",
                    "zip": "22607",
                    "country": "Germany",
                    "geoPoint": {
                        "lat": 53.57532,
                        "lon": 10.01534
                    }
                },
                {
                    "facility": "AmBeNet GmbH",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Leipzig",
                    "zip": "04107",
                    "country": "Germany",
                    "geoPoint": {
                        "lat": 51.33962,
                        "lon": 12.37129
                    }
                },
                {
                    "facility": "Institut f\u00fcr Diabetesforschung GmbH M\u00fcnster - Dr. med. Rose",
                    "status": "NOT_YET_RECRUITING",
                    "city": "M\u00fcnster",
                    "zip": "48145",
                    "country": "Germany",
                    "geoPoint": {
                        "lat": 51.96236,
                        "lon": 7.62571
                    }
                },
                {
                    "facility": "Forschungszentrum Ruhr KliFoCenter GmbH, Dr. med. Kahrmann",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Witten",
                    "zip": "58455",
                    "country": "Germany",
                    "geoPoint": {
                        "lat": 51.44362,
                        "lon": 7.35258
                    }
                },
                {
                    "facility": "The Health Centre",
                    "status": "RECRUITING",
                    "city": "Bradford-on-Avon",
                    "zip": "BA15 1DQ",
                    "country": "United Kingdom",
                    "geoPoint": {
                        "lat": 51.34772,
                        "lon": -2.25065
                    }
                },
                {
                    "facility": "Southmead Hospital",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Bristol",
                    "zip": "BS10 5NB",
                    "country": "United Kingdom",
                    "geoPoint": {
                        "lat": 51.45523,
                        "lon": -2.59665
                    }
                },
                {
                    "facility": "Addenbrooke's Hospital_Cambridge",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Cambridge",
                    "zip": "CB2 0QQ",
                    "country": "United Kingdom",
                    "geoPoint": {
                        "lat": 52.2,
                        "lon": 0.11667
                    }
                },
                {
                    "facility": "WISDEM Centre",
                    "status": "RECRUITING",
                    "city": "Coventry",
                    "zip": "CV2 2DX",
                    "country": "United Kingdom",
                    "geoPoint": {
                        "lat": 52.40656,
                        "lon": -1.51217
                    }
                },
                {
                    "facility": "The Staploe Medical Centre",
                    "status": "RECRUITING",
                    "city": "Soham",
                    "zip": "CB7 5JD",
                    "country": "United Kingdom",
                    "geoPoint": {
                        "lat": 52.33543,
                        "lon": 0.33654
                    }
                },
                {
                    "facility": "Joint Clinical Research Facility - Swansea",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Swansea",
                    "zip": "SA2 8PP",
                    "country": "United Kingdom",
                    "geoPoint": {
                        "lat": 51.62079,
                        "lon": -3.94323
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "YES",
            "description": "According to the Novo Nordisk disclosure commitment on novonordisk-trials.com",
            "url": "http://novonordisk-trials.com"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000009765",
                    "term": "Obesity"
                }
            ],
            "ancestors": [
                {
                    "id": "D000050177",
                    "term": "Overweight"
                },
                {
                    "id": "D000044343",
                    "term": "Overnutrition"
                },
                {
                    "id": "D000009748",
                    "term": "Nutrition Disorders"
                },
                {
                    "id": "D000001835",
                    "term": "Body Weight"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M5114",
                    "name": "Body Weight",
                    "relevance": "LOW"
                },
                {
                    "id": "M12701",
                    "name": "Obesity",
                    "asFound": "Obesity",
                    "relevance": "HIGH"
                },
                {
                    "id": "M26186",
                    "name": "Overweight",
                    "relevance": "LOW"
                },
                {
                    "id": "M18102",
                    "name": "Weight Loss",
                    "relevance": "LOW"
                },
                {
                    "id": "M25307",
                    "name": "Overnutrition",
                    "relevance": "LOW"
                },
                {
                    "id": "M12684",
                    "name": "Nutrition Disorders",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC18",
                    "name": "Nutritional and Metabolic Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "C000591245",
                    "term": "Semaglutide"
                }
            ],
            "ancestors": [
                {
                    "id": "D000097789",
                    "term": "Glucagon-Like Peptide-1 Receptor Agonists"
                },
                {
                    "id": "D000007004",
                    "term": "Hypoglycemic Agents"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M353561",
                    "name": "Semaglutide",
                    "asFound": "Stretching",
                    "relevance": "HIGH"
                },
                {
                    "id": "M9043",
                    "name": "Glucagon",
                    "relevance": "LOW"
                },
                {
                    "id": "M26997",
                    "name": "Glucagon-Like Peptide 1",
                    "relevance": "LOW"
                },
                {
                    "id": "M3401",
                    "name": "Glucagon-Like Peptide-1 Receptor Agonists",
                    "relevance": "LOW"
                },
                {
                    "id": "M10054",
                    "name": "Hypoglycemic Agents",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Hypo",
                    "name": "Hypoglycemic Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "Gast",
                    "name": "Gastrointestinal Agents"
                }
            ]
        }
    },
    "hasResults": false
}